Breast Cancer and Link to Hormone-Replacement Therapy Drugs: Trial Updates
A Philadelphia jury returned a $28 million punitive damages verdict Monday against two drugmakers over the drugmakers’ hormone-replacement therapy drugs that the jury found caused a plaintiff’s breast cancer. And a $75 million punitive damages verdict from the end of October in another hormone-replacement therapy, or HRT, mass tort case was unsealed by court order after the other jury verdict was rendered around 2 p.m. Monday.
On Friday, the jury in Kendall v. Wyeth awarded more than $6 million in compensatory damages to plaintiffs Donna Kendall and John Kendall Jr., their attorneys said. In the punitive damages part of the case decided Monday, the jury awarded $16 million against Wyeth, which is now owned by Pfizer, and $12 million against Pharmacia & Upjohn, which also is now owned by Pfizer. The total verdict adds up to more than $34 million.
Read the full article on law.com.
Related posts:
- Jury Decides Wyeth’s Prempro Caused Woman’s Cancer
- August 2009 Updates for Claimants in Silicone Gel Breast Implant Litigation
- Exxon Found Liable for Fouling New York City Water
- Pfizer Hit With $1.3 Billion Fine For Bextra Marketing
- Lincoln Electric, other welding companies, hit with $5.8 million verdict for welder injured by manganese
